The eclinical solutions market is expected to grow by USD 9.7 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of  13.47% during the forecast period, according to Technavio Research. The market has been segmented by end-user (pharmaceutical and biotechnology companies, contract research organizations, consulting service companies, medical device manufacturers, and others), deployment (cloud-based and on-premises), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America accounts for 41% of the growth of the global market during the forecast period. Factors such as the easy regulatory process, a large number of pharmaceutical and biotech companies as well as CROs in the region, and large investments in clinical trial research are driving the market growth in North America
Factors such as the easy regulatory process, a large number of pharmaceutical and biotech companies as well as CROs in the region, and large investments in clinical trial research are driving the market growth in North America
This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.
Key Company
Advarra Inc., Aixial, Anju Software Inc., ArisGlobal LLC, Castor Research Inc., Dassault Systemes SE, DATATRAK International Inc., eClinical Solutions LLC., eClinicalWorks LLC, eResearchTechnology GmbH, International Business Machines Corp., MedNet, Medrio Inc., OpenClinica LLC, Oracle Corp., Parexel International Corp., Saama Technologies Inc., Signant Health, Veeva Systems Inc., and YPrime LLC

Source prnewswire